Farther Finance Advisors, LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1992825 SAN FRANCISCO, CA

Position in REGN

as of Jun 30, 2026 · filed Jul 17, 2026 Compact

Position Value

$670,305

-$774,531 QoQ

Shares Held

1,075

-42.5% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#735

of 1,322 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Farther Finance Advisors, LLC holds $15,699,251 across 282 Biotechnology names. REGN ranks #6 (4.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	4,922	$2,444,905
2	MRNA	Moderna, Inc.	15,429	$1,080,492
3	ARWR	Arrowhead Pharmaceuticals, Inc.	12,088	$985,292
4	HALO	Halozyme Therapeutics, Inc.	11,241	$879,833
5	EXEL	Exelixis, Inc.	14,171	$771,044
6	REGN	Regeneron Pharmaceuticals, Inc. This page	1,075	$670,305
7	VKTX	Viking Therapeutics, Inc.	15,171	$591,820
8	BMRN	Biomarin Pharmaceutical Inc	7,871	$450,378

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$670,305	1,075	-42.5%	Shares	Sole	2026-07-17
2026-03-31	$1,444,836	1,870	-6.1%	Shares	Sole	2026-04-07
2025-12-31	$1,537,565	1,992	+34.7%	Shares	Sole	2026-01-23
2025-09-30	$831,597	1,479	+134.4%	Shares	Sole	2025-10-14
2025-06-30	$331,275	631	+0.5%	Shares	Sole	2025-07-11
2025-03-31	$398,296	628	+9.6%	Shares	Sole	2025-04-14
2024-12-31	$408,165	573	-20.9%	Shares	Sole	2025-02-10
2024-09-30	$761,097	724	+7.9%	Shares	Sole	2024-10-29
2024-06-30	$705,241	671	+4.8%	Shares	Sole	2024-07-31
2024-03-31	$615,993	640	+0.6%	Shares	Sole	2024-05-14
2023-12-31	$558,592	636	+30.6%	Shares	Sole	2024-02-15
2023-09-30	$400,781	487	+64.0%	Shares	Sole	2023-11-14
2023-06-30	$213,406	297	+175.0%	Shares	Sole	2024-05-14
2023-03-31	$88,740	108	+1.9%	Shares	Sole	2024-05-14
2022-12-31	$76,477	106	—	Shares	Sole	2023-09-12
No filing history on record for this holder in this stock.